Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bicara Therapeutics

11.01
+1.1111.21%
Volume:3.06M
Turnover:32.89M
Market Cap:600.44M
PE:-3.61
High:11.21
Open:9.98
Low:9.71
Close:9.90
Loading ...
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2025

Major Issues Report

Form 8-K - Current report
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 26, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 26, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 23, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 18, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 16, 2024

Major Issues Report

Form 8-K - Current report
Sep 13, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 11, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Sep 11, 2024

Correspondence

Form CORRESP - Correspondence
Sep 11, 2024

Correspondence

Form CORRESP - Correspondence
Sep 06, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Sep 03, 2024

Correspondence

Form CORRESP - Correspondence